{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hepatitis+Autoimmune+Disease", "query": { "condition": "Hepatitis Autoimmune Disease" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 31, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Hepatitis+Autoimmune+Disease&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-11-15T05:04:06.235Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04339621", "title": "AIH Risk Stratification With Multiparametric MRI", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Autoimmune Hepatitis" ], "interventions": [ { "name": "LiverMultiscan", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Perspectum", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 11, "start_date": "2020-10-20", "completion_date": "2023-04-15", "has_results": false, "last_update_posted_date": "2023-11-22", "last_synced_at": "2026-11-15T05:04:06.235Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04339621" }, { "nct_id": "NCT02440906", "title": "Evaluation of the Texas Wellness Incentives and Navigation (WIN) Project", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Mental Illness", "Chronic Physical Illness" ], "interventions": [ { "name": "Patient-Directed Wellness Account", "type": "BEHAVIORAL" }, { "name": "Health Navigator", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "21 Years to 55 Years" }, "enrollment_count": 1663, "start_date": "2012-06", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2017-10-03", "last_synced_at": "2026-11-15T05:04:06.235Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02440906" }, { "nct_id": "NCT07598825", "title": "A Trial of Inebilizumab in Participants With Autoimmune Hepatitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Autoimmune Hepatitis", "AIH" ], "interventions": [ { "name": "Inebilizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of Care", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 180, "start_date": "2026-12-18", "completion_date": "2034-02-11", "has_results": false, "last_update_posted_date": "2026-11-03", "last_synced_at": "2026-11-15T05:04:06.235Z", "location_count": 12, "location_summary": "Little Rock, Arkansas • Rialto, California • Valencia, California + 9 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rialto", "state": "California" }, { "city": "Valencia", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Largo", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07598825" }, { "nct_id": "NCT03842254", "title": "Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Autoimmune Hepatitis" ], "interventions": [ { "name": "Erythropoietin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 6, "start_date": "2019-01-25", "completion_date": "2021-02-18", "has_results": false, "last_update_posted_date": "2021-03-04", "last_synced_at": "2026-11-15T05:04:06.235Z", "location_count": 2, "location_summary": "Chicago, Illinois • New York, New York", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03842254" }, { "nct_id": "NCT03175471", "title": "MRI Based Biomarkers in Pediatric Autoimmune Liver Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Autoimmune Liver Disease", "Primary Sclerosing Cholangitis", "Autoimmune Hepatitis" ], "interventions": [], "intervention_types": [], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "23 Years", "sex": "ALL", "summary": "6 Years to 23 Years" }, "enrollment_count": 115, "start_date": "2017-01-17", "completion_date": "2030-01-30", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-11-15T05:04:06.235Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03175471" }, { "nct_id": "NCT05635266", "title": "Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Age-Related Macular Degeneration", "Allergies", "Alpha-Gal Syndrome", "Alzheimer Disease", "Amyloidosis", "Ankylosing Spondylitis", "Arthritis", "Alopecia Areata", "Asthma", "Atopic Dermatitis", "Autism", "Autoimmune Hepatitis", "Behcet's Disease", "Beta-Thalassemia", "Cancer", "Celiac Disease", "Kidney Diseases", "COPD", "Crohn Disease", "Cystic Fibrosis", "Diabetes", "Dravet Syndrome", "DMD", "Fibromyalgia", "Graves Disease", "Thyroid Diseases", "Hepatitis", "Hidradenitis Suppurativa", "ITP", "Leukemia", "ALS", "Lupus or SLE", "Lymphoma", "Multiple Sclerosis", "Myasthenia Gravis", "Heart Diseases", "Parkinson Disease", "Pemphigus Vulgaris", "Cirrhosis", "Psoriasis", "Schizophrenia", "Scleroderma", "Sickle Cell Disease", "Stroke", "Ulcerative Colitis", "Vasculitis", "Vitiligo" ], "interventions": [ { "name": "Specimen sample", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 20000, "start_date": "2021-10-26", "completion_date": "2025-10", "has_results": false, "last_update_posted_date": "2024-05-07", "last_synced_at": "2026-11-15T05:04:06.235Z", "location_count": 1, "location_summary": "Waltham, Massachusetts", "locations": [ { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05635266" }, { "nct_id": "NCT01931644", "title": "At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "All Diagnosed Health Conditions", "ADD/ADHD", "Alopecia Areata", "Ankylosing Spondylitis", "Asthma", "Atopic Dermatitis Eczema", "Beta Thalassemia", "Bipolar Disorder", "Breast Cancer", "Celiac Disease", "Cervical Cancer", "Chronic Inflammatory Demyelinating Polyneuropathy", "Chronic Kidney Diseases", "Chronic Obstructive Pulmonary Disease", "Colon Cancer", "Colorectal Cancer", "Crohn's Disease", "Cystic Fibrosis", "Depression", "Diabetes Mellitus", "Duchenne Muscular Dystrophy", "Endometriosis", "Epilepsy", "Facioscapulohumeral Muscular Dystrophy", "G6PD Deficiency", "General Anxiety Disorder", "Hepatitis B", "Hereditary Hemorrhagic Telangiectasia", "HIV/AIDS", "Human Papilloma Virus", "Huntington's Disease", "Idiopathic Thrombocytopenic Purpura", "Insomnia", "Kidney Cancer", "Leukemia", "Lung Cancer", "Lupus Nephritis", "Lymphoma", "Melanoma", "Multiple Myeloma", "Multiple Sclerosis", "Myositis", "Myotonic Dystrophy", "Ovarian Cancer", "Pancreatic Cancer", "Parkinson's Disease", "Polycystic Kidney Diseases", "Prostate Cancer", "Psoriasis", "Psoriatic Arthritis", "Rosacea", "Scleroderma", "Sickle Cell Anemia", "Sickle Cell Trait", "Sjogren's Syndrome", "Skin Cancer", "Spinal Muscular Atrophy", "Systemic Lupus Erythematosus", "Thrombotic Thrombocytopenic Purpura", "Trisomy 21", "Ulcerative Colitis" ], "interventions": [], "intervention_types": [], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 17667, "start_date": "2013-07", "completion_date": "2024-04", "has_results": false, "last_update_posted_date": "2024-04-18", "last_synced_at": "2026-11-15T05:04:06.235Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01931644" }, { "nct_id": "NCT03944447", "title": "Outcomes Mandate National Integration With Cannabis as Medicine", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Pain", "Chronic Pain Syndrome", "Chronic Pain Due to Injury", "Chronic Pain Due to Trauma", "Fibromyalgia", "Seizures", "Hepatitis C", "Cancer", "Crohn Disease", "HIV/AIDS", "Multiple Sclerosis", "Traumatic Brain Injury", "Sickle Cell Disease", "Post Traumatic Stress Disorder", "Tourette Syndrome", "Ulcerative Colitis", "Glaucoma", "Epilepsy", "Inflammatory Bowel Diseases", "Parkinson Disease", "Amyotrophic Lateral Sclerosis", "Chronic Traumatic Encephalopathy", "Anxiety", "Depression", "Insomnia", "Autism", "Opioid-use Disorder", "Bipolar Disorder", "Covid19", "SARS-CoV Infection", "COVID-19", "Corona Virus Infection", "Coronavirus" ], "interventions": [ { "name": "Cannabis, Medical", "type": "DRUG" }, { "name": "RYAH-Medtech Inhaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "OMNI Medical Services, LLC", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Years", "maximum_age": null, "sex": "ALL", "summary": "7 Years and older" }, "enrollment_count": 200000, "start_date": "2018-12-01", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2022-06-02", "last_synced_at": "2026-11-15T05:04:06.235Z", "location_count": 17, "location_summary": "Boca Raton, Florida • Bradenton, Florida • Fort Lauderdale, Florida + 13 more", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "Bradenton", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03944447" }, { "nct_id": "NCT02950077", "title": "Mindfulness - Based Stress Reduction and the Relationship on Inflammation in Autoimmune Hepatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Autoimmune Hepatitis" ], "interventions": [ { "name": "mindfulness based stress reduction", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 21, "start_date": "2017-04-14", "completion_date": "2020-04-14", "has_results": false, "last_update_posted_date": "2020-07-02", "last_synced_at": "2026-11-15T05:04:06.235Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02950077" }, { "nct_id": "NCT05750498", "title": "A-LiNK: Improving Outcomes in Autoimmune Liver Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Autoimmune Hepatitis", "Primary Sclerosing Cholangitis" ], "interventions": [ { "name": "No interventions", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 800, "start_date": "2022-04-28", "completion_date": "2033-06-30", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-11-15T05:04:06.235Z", "location_count": 8, "location_summary": "Palo Alto, California • Indianapolis, Indiana • St Louis, Missouri + 5 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05750498" } ] }